company
Zydus Pharmaceuticals (USA) Inc
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_approval · anda2026-06-30ZYDUS PHARMS — ANDA approval: SELENIOUS ACID (unspecified)
- fda_warning_letter · cgmp2026-06-02Zydus Lifesciences Limited — Request for Records/CGMP/Finished Pharmaceuticals/Adulterated (2026-06-02)
- fda_recall · drug_recall2026-05-27Zydus Pharmaceuticals (USA) Inc — Class II recall: Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactured…
- fda_recall · drug_recall2026-05-27Zydus Pharmaceuticals (USA) Inc — Class II recall: Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactured…
Frequently asked questions
- How many FDA warning letters has Zydus Pharmaceuticals (USA) Inc received?
- Argus HQ has recorded 1 FDA warning letter for Zydus Pharmaceuticals (USA) Inc.
- What FDA recalls has Zydus Pharmaceuticals (USA) Inc issued?
- Argus HQ has recorded 2 FDA recalls tied to Zydus Pharmaceuticals (USA) Inc.
- Is Zydus Pharmaceuticals (USA) Inc FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 1 warning letter, 2 recalls, and 1 approval record for Zydus Pharmaceuticals (USA) Inc. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.